MCMedicalCodingSoftware
Free trial
3E0L317

3E0L317 — Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Oth Thrombolytic in Pleural Cav, Perc

How 3E0L317 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. LBody partThe specific site
  5. 3ApproachHow the site was reached
  6. 1DeviceWhat was left in place, if anything
  7. 7QualifierA further distinction where one applies

Codes near 3E0L317

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0K8KZIntroduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0K8NZIntroduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0K8SFIntroduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0K8TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0L05ZIntroduction of Adhesion Barrier into Pleural Cavity, Open Approach
  • 3E0L304Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach
  • 3E0L305Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach
  • 3E0L30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
  • 3E0L317Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach
  • 3E0L328Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach
  • 3E0L329Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach
  • 3E0L33ZIntroduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach
  • 3E0L35ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach
  • 3E0L36ZIntroduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach
  • 3E0L37ZIntroduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach
  • 3E0L3BZIntroduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach
  • 3E0L3GCIntroduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach
ICD-10-PCSFY2026